Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience.
  • Home
  • About Us
    • Management Team
    • Board of Directors
  • Products in Development
    • Intermezzo®
  • Investors
    • Press Releases
    • Events & Presentations
    • SEC Filings
    • Corporate Governance
      • Management Team
      • Board of Directors
      • Committee Composition
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
    • Analysts
    • Shareholder Tools
      • Shareholder Briefcase
      • Printed Materials
      • Email Alerts
  • Careers
  • Contact
 
 

News & Events

    Tuesday, March 9, 2010

    Transcept Pharmaceuticals to Report Fourth Quarter and Full Year 2009 Results and Host Conference Call on March 23, 2010

    Monday, February 22, 2010

    Transcept Pharmaceuticals Provides Update on Intermezzo(R) Regulatory Review

    Tuesday, February 9, 2010

    Transcept Pharmaceuticals Granted First U.S. Patent Covering Intermezzo(R) Formulation

    Monday, December 14, 2009

    Transcept Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent Application Covering Intermezzo(R)

Transcept Stock Quote
Copyright © 2010  |  
Sitemap  |  Contact Us